PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

safinamide

Verify with FDA → · CMS NADAC pricing →

Brand names: Xadago

MAO-B Inhibitor Rx

Safinamide (Xadago) is a drug used with levodopa/carbidopa to treat Parkinson's disease. It helps reduce "off" episodes, where symptoms like stiffness and slowness return.

Drug Pricing (NADAC)

Brand Price

$36.56/unit

Generic Available

No

MDD US

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

Safinamide is used to treat Parkinson's disease.

Common side effects

Uncontrolled movements (dyskinesia), Falls, Feeling sick to your stomach (nausea)

Key warnings

Safinamide can cause or worsen high blood pressure.

How It Works

Safinamide is a MAO-B inhibitor. It works by blocking an enzyme in the brain that breaks down dopamine. This helps increase the amount of dopamine available, which can improve motor control.

How to Take It

Take safinamide once a day at the same time each day. You can take it with or without food. The starting dose is usually 50 mg daily. After two weeks, your doctor may increase it to 100 mg daily.

Pregnancy & Breastfeeding

Safinamide may harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if safinamide passes into breast milk, so talk to your doctor if you are breastfeeding.

Missed Dose

If you miss a dose, take your next dose at the same time the next day. Do not take two doses at once to make up for the missed dose.

Storage

Store safinamide at room temperature, between 59°F and 86°F.

Side Effects (from patient reports)

Based on 1,022 FDA adverse event reports.

Fall
154
Seeing or hearing things that are not there
142
Uncontrolled movements
137
Trouble walking
93
Death
90
Parkinson's disease
89
The drug is not working
86
Shaking
81
Tiredness
76
Sudden inability to move
74

FDA Adverse Event Report Analysis

Detailed analysis of 1,205 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2016–2025.

Total Reports

1,205

Death-Related Reports

151

Hospitalization Reports

496

Top Indication

Parkinson^S Disease

Gender Distribution

Female 456 (41%)
Male 648 (59%)

Age Distribution

0–17 2
18–44 10
45–64 143
65–74 330
75+ 324

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 FALL 154
2 HALLUCINATION 142
3 DYSKINESIA 137
4 GAIT DISTURBANCE 93
5 DEATH 90
6 PARKINSON^S DISEASE 89
7 DRUG INEFFECTIVE 86
8 TREMOR 81
9 FATIGUE 76
10 FREEZING PHENOMENON 74
11 ON AND OFF PHENOMENON 72
12 SOMNOLENCE 64
13 ANXIETY 61
14 NAUSEA 60
15 DIZZINESS 56

Reactions in Death Reports

DEATH 90
GENERAL PHYSICAL HEALTH DETERIORATION 16
PARKINSON^S DISEASE 12
FALL 11
VOMITING 9
DYSKINESIA 8
EPILEPSY 7
MYOCARDIAL INFARCTION 7
DYSPHAGIA 6
HALLUCINATION 6

Reactions in Hospitalization Reports

FALL 107
HALLUCINATION 69
DYSKINESIA 61
PARKINSON^S DISEASE 39
ON AND OFF PHENOMENON 38
GAIT DISTURBANCE 37
HYPERKINESIA 33
GENERAL PHYSICAL HEALTH DETERIORATION 31
WEIGHT DECREASED 31
MOBILITY DECREASED 30

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Safinamide can cause or worsen high blood pressure. It can also cause serotonin syndrome, a dangerous condition, if taken with certain other medicines. Some people taking safinamide have fallen asleep suddenly during normal activities. Safinamide may also cause or worsen uncontrolled movements, hallucinations, and compulsive behaviors. Stopping safinamide suddenly can cause serious withdrawal symptoms.

Known Drug Interactions

7.2 Opioid Drugs Because serious, sometimes fatal reactions have been precipitated with concomitant use of opioid drugs (e.g., meperidine and its derivatives, methadone, propoxyphene, or tramadol) and MAOIs, including selective MAO-B inhibitors, concomitant use of these drugs is contraindicated [see Warnings and Precautions (5.2) ] .

Mechanism: Combining these drugs can cause a dangerous buildup of serotonin in the brain, which may lead to a life-threatening reaction.

What to do: Do not take these two medications together.

Concomitant use of XADAGO with methylphenidate, amphetamine, and their derivatives is contraindicated [see Warnings and Precautions (5.1 , 5.2) ] .

Mechanism: These drugs both increase certain brain chemicals that can cause your blood pressure to rise to dangerous levels.

What to do: Avoid using these medications at the same time.

7 DRUG INTERACTIONS Selective Serotonin Reuptake Inhibitors: Monitor patients for serotonin syndrome ( 7.3 ) Sympathomimetic Medications: Monitor patients for hypertension ( 7.5 ) Tyramine: Risk of severe hypertension ( 7.6 ) 7.1 MAO Inhibitors (MAOIs) XADAGO is contraindicated for use with other drugs in the MAOIs class or other drugs that are potent inhibitors of monoamine oxidase (e.g., linezolid, an oxazolidinone antibacterial, which also has reversible nonselective MAO inhibition activity).

Mechanism: Both drugs stop the body from breaking down certain chemicals, which can lead to a toxic buildup in your system.

What to do: This combination is not allowed and should be avoided.

7.2 Opioid Drugs Because serious, sometimes fatal reactions have been precipitated with concomitant use of opioid drugs (e.g., meperidine and its derivatives, methadone, propoxyphene, or tramadol) and MAOIs, including selective MAO-B inhibitors, concomitant use of these drugs is contraindicated [see Warnings and Precautions (5.2) ] .

Mechanism: Taking these together can cause a very serious and potentially fatal reaction in the brain and nervous system.

What to do: Do not use these two drugs together.

7.2 Opioid Drugs Because serious, sometimes fatal reactions have been precipitated with concomitant use of opioid drugs (e.g., meperidine and its derivatives, methadone, propoxyphene, or tramadol) and MAOIs, including selective MAO-B inhibitors, concomitant use of these drugs is contraindicated [see Warnings and Precautions (5.2) ] .

Mechanism: This combination can cause a severe, life-threatening reaction by interfering with how the brain handles certain chemicals.

What to do: Avoid taking these medications together under any circumstances.

Check all your medications →

Common Questions

Can I take safinamide if I have liver problems?
If you have moderate liver problems, your doctor may prescribe a lower dose (50 mg). If you have severe liver problems, you should not take safinamide.
Can I eat whatever I want while taking safinamide?
You don't need to avoid most foods. However, avoid foods with very high amounts of tyramine (over 150mg), as this could cause dangerously high blood pressure.
What should I do if I experience side effects?
Tell your doctor about any side effects you experience while taking safinamide.
Can I take safinamide with my other Parkinson's medications?
Safinamide is meant to be taken with levodopa/carbidopa. Talk to your doctor about all the medications you are taking.
How long does it take for safinamide to start working?
It may take a few weeks to see the full effects of safinamide. Talk to your doctor if you don't notice any improvement.
Can safinamide cause high blood pressure?
Yes, safinamide can cause or worsen high blood pressure. Your doctor will monitor your blood pressure.
What if I want to stop taking safinamide?
Talk to your doctor before stopping safinamide. You may need to lower the dose slowly to avoid withdrawal symptoms.
Can safinamide cause me to fall asleep suddenly?
Yes, safinamide can cause some people to fall asleep suddenly, even during normal activities. Be careful when driving or operating machinery.
Is safinamide a cure for Parkinson's disease?
No, safinamide does not cure Parkinson's disease. It helps manage the symptoms.
Are there any foods I should avoid while taking safinamide?
Avoid foods containing very high amounts of tyramine, such as aged cheeses and cured meats.
What are the common side effects of safinamide?
The most commonly reported side effects of safinamide include Uncontrolled movements (dyskinesia), Falls, Feeling sick to your stomach (nausea), Trouble sleeping (insomnia). Based on 1,022 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does safinamide interact with other medications?
Yes, safinamide has 10 known drug interactions. Notable interactions include tramadol, methylphenidate, linezolid. Always inform your doctor about all medications you are taking.
What drug class is safinamide?
safinamide belongs to the MAO-B Inhibitor drug class. It requires a prescription (Rx). Safinamide is used to treat Parkinson's disease.
Is safinamide safe during pregnancy?
Safinamide may harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in MAO-B Inhibitor

Other drugs grouped near safinamide — same-class peers and common alternatives.

Compare safinamide vs acamprosate side-by-side →

Medication Guides

Related Health & Safety Data

Save on safinamide

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for safinamide

The FDA label for safinamide (sold under brand names such as Xadago) classifies it as a prescription-only medication in the MAO-B Inhibitor class. Safinamide is used to treat Parkinson's disease. Official labeling lists 4 commonly reported side effects, including Uncontrolled movements (dyskinesia), Falls, Feeling sick to your stomach (nausea).

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 1,022 voluntary reports. The database also lists 10 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: October 22, 2025

All federal data sources used on this page